San Diego, CA -- (SBWIRE) -- 02/23/2015 -- A deadline is coming up on February 23, 2015 in the lawsuit filed for investors of Roka Bioscience Inc (NASDAQ:ROKA) over alleged Securities Laws Violations by Roka Bioscience.

Investors who purchased shares of Roka Bioscience Inc (NASDAQ:ROKA) have certain options and there are strict and short deadlines running. Deadline: February 23, 2015. NASDAQ:ROKA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Roka Bioscience Inc (NASDAQ:ROKA) common shares between July 17, 2014 and November 6, 2014, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that Roka Bioscience Inc 's initial public offering ("IPO") documents allegedly failed to disclose known trends and uncertainties about the drastic decline in demand for its Atlas instruments that existed at the time of the IPO.

On November 6, 2014 Roka Bioscience Inc reported its third quarter 2014 financial results. Roka Bioscience reports a Net Loss for the third quarter was $9.1 million, or a loss of $(0.64) per share, compared with $9.4 million, or a loss of $(17.00) per share, for the same period in 2013. Additionally, Roka Bioscience Inc reported that there were no new Atlas® instruments placements made during the quarter. Shares of Roka Bioscience Inc (NASDAQ:ROKA) declined to as low as $2.97 per share on November 7, 2014.

On February 19, 2015, NASDAQ:ROKA shares closed at $4.26 per share.

Those who purchased shares of Roka Bioscience Inc (NASDAQ:ROKA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com